A NEW POSSIBILITY FOR WEIGHT REGULATION?

Experts are increasingly focused on retatrutide, a promising drug developed by Eli Lilly, as a possible step in body reduction . Unlike many earlier approaches, retatrutide is a twin-action compound targeting simultaneously GLP-1 and GIP, hormones that affect appetite and blood glucose control .